Fhdah S. Alanazi

Fhdah S. Alanazi

Pharmacy, Pharmaceutical Chemistry, King Saud University, Riyadh, Ar Riyāḑ, Saudi Arabia
orcid
PhD Candidate at King Saud Univeristy, Scientific Evaluator ...

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2023 in Crystals
Verified
Journal Article
Open access
PDF file
AAAbdulrahman Almehizia
Abdulrahman Almehizia
Mohamed A. Al-OmarMohamed A. Al-Omar
Mohamed A. Al-Omar
ANAhmed Mohamed Naglah
Ahmed Mohamed Naglah
Mashooq Ahmad BhatMashooq Ahmad Bhat
Mashooq Ahmad Bhat
FAFhdah S. Alanazi
Fhdah S. Alanazi
Abdel Majid AdamAbdel Majid Adam
Abdel Majid Adam
The chemical reaction between quinolone antibiotic oxolinic acid (OA) and Fe(III), Zn(II), Ca(II), and Mg(II) ions results in the formation of metal-based complexes with the following formulas: [Fe(OA)(H2O)2Cl2]·2H2O, [Zn(OA)(H2O)Cl]·2H2O, [Ca(OA)(H2O)Cl], and [Mg(OA)(H2O)Cl]. We used analytical (C, N, H, Cl, metal analysis) and spectral (FT-IR, 1H NMR, UV-visible) data to structurally characterize the synthesized metal-based complexes of the OA molecule. We found that the OA molecule utilizes the two oxygen atoms of the carboxylate group and the pyridone C=O group to bind the investigated metal ions. The morphological properties of the synthesized OA complexes were assessed using X-ray powder diffractometry (XRD), scanning electron microscopy (SEM), and transmission electron microscopy (TEM). The biological properties, specifically antibacterial and antifungal activity, of the synthesized complexes were evaluated in vitro using the Kirby–Bauer disc diffusion protocol with five bacterial and three fungal strains. The complex containing Ca(II) ions exhibited remarkable antibacterial and antifungal activity against all tested microbial strains, surpassing or equaling the potency of the standard drugs (streptomycin for antibacterial assays and ketoconazole for antifungal assays).

28 March 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
FAFhdah S. Alanazi
Fhdah S. Alanazi
HAHamad Alkahtani
Hamad Alkahtani
AAAlaa Abdel-Aziz
Alaa Abdel-Aziz
AAAdel Azab
Adel Azab
HAHanadi Hussain Asiri
Hanadi Hussain Asiri
FAFatmah Abdulaziz MOHAMMED Alomary
Fatmah Abdulaziz MOHAMMED Alomary
Background/Objective: Cancer is the leading cause of death worldwide despite the diversity of antitumor therapies, which highlights the necessity to explore new anticancer agents. Methods: We synthesized 5,5-diphenylhydantoin derivatives including Schiff’s bases 7–27 and evaluated their cytotoxicity via the MTT assay. Enzymatic inhibition assays, cell cycle and apoptosis analyses, and molecular docking studies were also conducted. Results: Derivative 24 demonstrated the highest cytotoxic activity, with IC50 values of 12.83 ± 0.9 μM, 9.07 ± 0.8 μM, and 4.92 ± 0.3 μM against the cell lines HCT-116, HePG-2, and MCF-7, respectively. Compounds 10, 13, and 21 showed potent antitumor activities versus the examined cell lines (average IC50 = 13.2, 14.5, and 13.1 μM), respectively; moreover, these compounds also demonstrated promising EGFR and HER2 inhibitory activities, with IC50 values in the range 0.28–1.61 µM. Derivative 24 displayed the highest EGFR and HER2 inhibitory activity values (IC50 = 0.07 and 0.04 µM), respectively, which were close to those of the reference drugs erlotinib and lapatinib. Therefore, compound 24 was selected for further examinations and exhibited an inducing effect on apoptosis via diminishing the anti-apoptotic protein levels of BCL-2 (8.598 ± 0.29 ng/mL) and MCL-1 (261.20 ± 8.97 pg/mL) and promoting cell cycle arrest at the G2/M phase (33.46%). The binding relationships between compound 24 and the active sites of EGFR and HER2, which are similar to the co-crystallized inhibitors, were investigated using a molecular docking approach. Conclusions: These findings provide insights into the potential anticancer activities of the synthesized derivatives for further optimization to achieve therapeutic use.

27 July 2023 in Crystals
Verified
Journal Article
Open access
PDF file
AAAbdulrahman Almehizia
Abdulrahman Almehizia
ANAhmed Mohamed Naglah
Ahmed Mohamed Naglah
Mohamed A. Al-OmarMohamed A. Al-Omar
Mohamed A. Al-Omar
Mashooq Ahmad BhatMashooq Ahmad Bhat
Mashooq Ahmad Bhat
FAFhdah S. Alanazi
Fhdah S. Alanazi
Abdel Majid AdamAbdel Majid Adam
Abdel Majid Adam
Chenodeoxycholic acid (CA) is a naturally occurring bile acid that is produced in the liver from cholesterol. Three CA complexes using Zn(II), Mg(II), and Ca(II) ions were synthesized to examine the chelation tendencies of CA towards these metal ions. The complexation reaction of CA with the metal ions under investigation was conducted with a 1:1 molar ratio (CA to metal) at 60–70 °C in neutralized media, which consisted of a binary solvent of MeOH and H2O (1:1). The resulting CA complexes were characterized using elemental data (metal, H, C, and Cl analysis) and spectral data (UV–visible, FT-IR, and 1H NMR). The results suggested that CA in anion form utilized oxygen atoms of the carboxylate group (-COO−) to capture Zn(II), Mg(II), and Ca(II) ions. This produced complexes with the general compositions of [Zn(CA)(H2O)Cl], [Mg2(CA)2(H2O)4Cl2], and [Ca2(CA)2(H2O)4Cl2]·2H2O, respectively. The Kirby–Bauer disc diffusion assay was then used to explore the bioactivity of the CA complexes toward three fungal species (Aspergillus niger, Candida albicans, and Penicillium sp.), three Gram-positive bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and Bacillus subtilis), and two Gram-negative bacteria (Pseudomonas aeruginosa and Escherichia coli). The Ca(II) and Mg(II) complexes exhibited marked inhibitory effects on the cell growth of the fungal species Aspergillus niger with potency equal to 127 and 116% of the activity of the positive control, respectively. The Zn(II) and Ca(II) complexes strongly inhibited the growth of Penicillium sp., while the Zn(II) and Mg(II) complexes showed strong growth inhibition towards the Gram-negative species Pseudomonas aeruginosa.

5 June 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
AAAbdulrahman Almehizia
Abdulrahman Almehizia
Mohamed A. Al-OmarMohamed A. Al-Omar
Mohamed A. Al-Omar
ANAhmed Mohamed Naglah
Ahmed Mohamed Naglah
Mashooq Ahmad BhatMashooq Ahmad Bhat
Mashooq Ahmad Bhat
FAFhdah S. Alanazi
Fhdah S. Alanazi
Abdel Majid AdamAbdel Majid Adam
Abdel Majid Adam
The chemical reaction between the quinolone antibiotic oxolinic acid (OA) and Fe(III), Zn(II), Ca(II), and Mg(II) ions results in the formation of metal-based complexes with the following formulas: [Fe(OA)(H2O)2Cl2]2H2O, [Zn(OA)(H2O)Cl]2H2O, [Ca(OA)(H2O)Cl], and [Mg(OA)(H2O)Cl]. We used analytical (C, N, H, Cl, metal analysis) and spectral (FT-IR, 1H NMR, UV-visible) data to structurally characterize the synthesized metal-based complexes of the OA molecule. We found that the OA molecule utilizes the two oxygen atoms of the carboxylate group and the pyridone C=O group to bind the investigated metal ions. The morphological properties of the synthesized OA complexes were assessed using X-ray powder diffractometry (XRD), scanning electron microscopy (SEM), and transmission electron microscopy (TEM). The biological properties, specifically antibacterial and antifungal activity, of the synthesized complexes were evaluated in vitro using the Kirby-Bauer disc diffusion protocol with five bacterial and three fungal strains. The complex containing Ca(II) ions exhibited remarkable antibacterial and antifungal activity against all tested microbial strains, surpassing or equaling the potency of the standard drugs (streptomycin for antibacterial assays and ketoconazole for antifungal assays).

5 July 2023 in Zeitschrift für Kristallographie - New Crystal Structures
Verified
Journal Article
Open access
PDF file
FAFatmah Abdulaziz MOHAMMED Alomary
Fatmah Abdulaziz MOHAMMED Alomary
OBOlivier BLACQUE
Olivier BLACQUE
FAFhdah S. Alanazi
Fhdah S. Alanazi
Edward Richard Tom TiekinkEdward Richard Tom Tiekink
Edward Richard Tom Tiekink
AEAli El-Emam
Ali El-Emam
C13H8Br2N2OS2, monoclinic, Pc (no. 7), a = 13.4050(4) Å, b = 4.7716(1) Å, c = 11.7303(4) Å, β = 105.885 ( 3 ) ∘ $105.885{(3)}^{\circ }$ , V = 721.66(4) Å3, Z = 2, R g t ${R}_{gt}$ (F) = 0.0294, w R r e f $w{R}_{ref}$ (F 2 = 0.0808, T = 160 K.